nsc-172755 has been researched along with Hyperphosphatemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adjagba, M; Alao, MJ; Arveiler, B; Ayivi, B; Coupry, I; Darboux, RB; Gbessi, G; Lacombe, D; Laleye, A; Lepreux, S; Marche, M; Redonnet-Vernhet, I | 1 |
1 other study(ies) available for nsc-172755 and Hyperphosphatemia
Article | Year |
---|---|
Tumoral calcinosis due to GALNT3 C.516-2A >T mutation in a black African family.
Topics: Adolescent; Adult; Amelogenesis Imperfecta; Apatites; Benin; Black People; Calcinosis; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Joint Diseases; Male; Mutation; N-Acetylgalactosaminyltransferases; Pedigree; Polypeptide N-acetylgalactosaminyltransferase; Siblings | 2008 |